Submission Details
| 510(k) Number | K243060 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 27, 2024 |
| Decision Date | January 30, 2025 |
| Days to Decision | 125 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K243060 is an FDA 510(k) clearance for the TeleRPM Gen2 Blood Glucose Monitoring System, a System, Test, Blood Glucose, Over The Counter (Class II — Special Controls, product code NBW), submitted by Guangdong Transtek Medical Electronics Co., Ltd. (Zhongshan, CN). The FDA issued a Cleared decision on January 30, 2025, 125 days after receiving the submission on September 27, 2024. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1345.
| 510(k) Number | K243060 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 27, 2024 |
| Decision Date | January 30, 2025 |
| Days to Decision | 125 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | NBW — System, Test, Blood Glucose, Over The Counter |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1345 |